Brief: Inspira Technologies Oxy BHN Plans FDA Submission For Hyla Blood Sensor In H2 2025
04/03/2025 13:56
March 4 (Reuters) - Inspira Technologies Oxy BHN Ltd IINN.O: INSPIRA TECHNOLOGIES OXY BHN LTD - PLANS FDA SUBMISSION FOR HYLA BLOOD SENSOR IN H2 2025 INSPIRA TECHNOLOGIES OXY BHN LTD - ANNOUNCES 96% ACCURACY IN HYLA BLOOD SENSOR STUDY Source text: ID:nPn8ZgLtma Further company coverage: IINN.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM